Cytosorbents Corporation (CTSO)

Last Closing Price: 0.59 (2026-04-06)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Cytosorbents Corporation (CTSO) had Net Income of $-5.50M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$9.23M
Net Income
$-5.50M
$2.43M
$6.80M
$13.62M
$-4.38M
$-1.11M
$-5.50M
$-5.50M
$-5.50M
$-5.50M
$-5.50M
$-5.50M
$-4.38M
$-3.75M
62.23M
62.23M
$-0.09
$-0.09
Balance Sheet Financials
$20.63M
$7.82M
$23.55M
$44.18M
$9.71M
$16.67M
$28.57M
$38.28M
$5.90M
$2.68M
$5.90M
62.80M
Cash Flow Statement Financials
$-12.38M
$-0.41M
$9.31M
$9.76M
$7.77M
$-1.99M
$2.77M
--
--
Fundamental Metrics & Ratios
2.13
--
--
0.74
2.82
73.68%
-47.49%
-47.49%
--
-59.53%
-59.53%
$-12.46M
--
--
--
0.21
0.46
1.22
73.59
-93.12%
-205.33%
-12.44%
-24.35%
$0.09
$-0.20
$-0.20